Cagrilintide vs Psyllium Husk for appetite
Short answer: For appetite, users rate them about the same: 100% report improvement with Cagrilintide (8 reports) and 100% with Psyllium Husk (9 reports).
Cagrilintide has 9 meta-analyses and 15 randomized trials on PubMed; Psyllium Husk has 49 and 145.
Based on 32 reports about Cagrilintide and 147 about Psyllium Husk. Not medical advice.
| Cagrilintide Peptide | Psyllium Husk Supplement | |
|---|---|---|
| Users say it helped | 82%helped11 reports · few reports | 78%helped87 reports · medium confidence |
| Verdict | Mostly positive | Mostly positive |
| Research | AResearch: Strong | AResearch: Strong |
| Meta-analyses / RCTs | 9 / 15 | 49 / 145 |
| Mainly used for | ||
| Digestion % reporting improvement | — | 89% (84) |
| Appetite % reporting improvement | 100% (8) | 100% (9) |
| Heart & lipids % reporting improvement | — | 100% (13) |
| Weight loss % reporting improvement | 100% (7) | 100% (4) |
| Common side effects | fatigue, appetite loss, depressive episode | stomach issues, dizziness, gagging/nausea from, blockage risk |
| Typical dose reported | Not listed | 5 g |
GLP-1RAs are efficacious in treating adults with type 2 diabetes. Compared with the placebo, tirzepatide was the most effective GLP-1RA drug for glycaemic control by reducing haemoglobin A1c and fasting plasma glucose concentrations. GLP-1RAs also significantly improved weight management for type 2 diabetes, with CagriSema performing the best for weight loss. The results prompt safety concerns for GLP-1RAs, especially with high dose administration, regarding gastrointestinal adverse events.
BMJ, 2024 ↗“Cagri was a game changer for me. I added 1mg and thats been more than enough.”
Several foods distinctly modify LDL cholesterol levels. The results may aid future guidelines and dietary advice for hypercholesterolemia.
Nutr Metab Cardiovasc Dis, 2021 ↗“It helped me heal my intestinal issues. I felt amazing after about a week and my mental clarity and energy skyrocketed.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate